189 related articles for article (PubMed ID: 32872551)
1. Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies.
Singh K; Jamshidi N; Zomer R; Piva TJ; Mantri N
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872551
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
Roberto D; Klotz LH; Venkateswaran V
Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor as a novel target for the treatment of prostate cancer.
Sarfaraz S; Afaq F; Adhami VM; Mukhtar H
Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356
[TBL] [Abstract][Full Text] [Related]
5. The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer.
Xian S; Parayath NN; Nehoff H; Giles NM; Greish K
Anticancer Res; 2015 Sep; 35(9):4707-12. PubMed ID: 26254360
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids in the treatment of cancer.
Alexander A; Smith PF; Rosengren RJ
Cancer Lett; 2009 Nov; 285(1):6-12. PubMed ID: 19442435
[TBL] [Abstract][Full Text] [Related]
7. Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsy.
Vinogradova LV; van Rijn CM
Pharmacol Rep; 2015 Jun; 67(3):501-3. PubMed ID: 25933961
[TBL] [Abstract][Full Text] [Related]
8. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
Slivicki RA; Xu Z; Mali SS; Hohmann AG
Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
[TBL] [Abstract][Full Text] [Related]
9. Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.
Pietrovito L; Iozzo M; Bacci M; Giannoni E; Chiarugi P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991773
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
[TBL] [Abstract][Full Text] [Related]
11. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer.
Greish K; Mathur A; Al Zahrani R; Elkaissi S; Al Jishi M; Nazzal O; Taha S; Pittalà V; Taurin S
J Control Release; 2018 Dec; 291():184-195. PubMed ID: 30367922
[TBL] [Abstract][Full Text] [Related]
14. A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain.
Kehl LJ; Hamamoto DT; Wacnik PW; Croft DL; Norsted BD; Wilcox GL; Simone DA
Pain; 2003 May; 103(1-2):175-86. PubMed ID: 12749972
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity.
Grambow E; Strüder D; Klar E; Hinz B; Vollmar B
Biofactors; 2016 Nov; 42(6):581-590. PubMed ID: 27151562
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids attenuate cancer pain and proliferation in a mouse model.
Saghafi N; Lam DK; Schmidt BL
Neurosci Lett; 2011 Jan; 488(3):247-51. PubMed ID: 21094209
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.
Xu D; Wang J; Zhou Z; He Z; Zhao Q
Mol Med Rep; 2015 Dec; 12(6):7963-70. PubMed ID: 26500101
[TBL] [Abstract][Full Text] [Related]
18. Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice.
Chen R; Zhao Y; Huang Y; Yang Q; Zeng X; Jiang W; Liu J; Thrasher JB; Forrest ML; Li B
Prostate; 2015 May; 75(6):593-602. PubMed ID: 25620467
[TBL] [Abstract][Full Text] [Related]
19. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
PLoS One; 2015; 10(9):e0137589. PubMed ID: 26352139
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
